A Study to Assess Efficacy/Safety of Ladarixin in Type 1 Diabetes Patients With Preserved ß-cell Function at Baseline.
Clinical trial NCT04899271 · TERMINATED
Trial details
- NCT number
- NCT04899271
- Sponsor
- Dompé Farmaceutici S.p.A
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-14
- Primary completion
- 2023-04-27
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.